First Manhattan CO Dia Medica Therapeutics Inc. Transaction History
First Manhattan CO
- $33.1 Billion
- Q2 2025
A detailed history of First Manhattan CO transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, First Manhattan CO holds 606,435 shares of DMAC stock, worth $3.17 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
606,435
Previous 606,435
-0.0%
Holding current value
$3.17 Million
Previous $2.3 Million
2.92%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding DMAC
# of Institutions
62Shares Held
5.97MCall Options Held
14.1KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA1.54MShares$8.01 Million0.0% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX650KShares$3.39 Million4.32% of portfolio
-
Geode Capital Management, LLC Boston, MA630KShares$3.29 Million0.0% of portfolio
-
Bleichroeder LP New York, NY382KShares$2 Million0.47% of portfolio
-
Northern Trust Corp Chicago, IL325KShares$1.69 Million0.0% of portfolio
About DiaMedica Therapeutics Inc.
- Ticker DMAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,443,100
- Market Cap $138M
- Description
- DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...